173 related articles for article (PubMed ID: 18922985)
1. Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.
Brunelli SM; Lynch KE; Ankers ED; Joffe MM; Yang W; Thadhani RI; Feldman HI
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1733-40. PubMed ID: 18922985
[TBL] [Abstract][Full Text] [Related]
2. Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients.
Lin FJ; Zhang X; Huang LS; Ji G; Huang HD; Xie Y; Jiang GR; Zhou X; Lu W
Int Urol Nephrol; 2018 Sep; 50(9):1703-1712. PubMed ID: 29974406
[TBL] [Abstract][Full Text] [Related]
3. Association of anemia with outcomes in men with moderate and severe chronic kidney disease.
Kovesdy CP; Trivedi BK; Kalantar-Zadeh K; Anderson JE
Kidney Int; 2006 Feb; 69(3):560-4. PubMed ID: 16395253
[TBL] [Abstract][Full Text] [Related]
4. Should asymptomatic patients discharged with lower hemoglobin expect worse outcomes after valve surgery?
Ad N; Holmes SD; Shuman DJ; Speir AM; Pritchard G; Halpin L
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1322-8. PubMed ID: 26318009
[TBL] [Abstract][Full Text] [Related]
5. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
[TBL] [Abstract][Full Text] [Related]
6. Association between long-term blood pressure variability and mortality among incident hemodialysis patients.
Brunelli SM; Thadhani RI; Lynch KE; Ankers ED; Joffe MM; Boston R; Chang Y; Feldman HI
Am J Kidney Dis; 2008 Oct; 52(4):716-26. PubMed ID: 18752875
[TBL] [Abstract][Full Text] [Related]
7. Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.
Kleine CE; Soohoo M; Ranasinghe ON; Park C; Marroquin MV; Obi Y; Rhee CM; Moradi H; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Nephrol; 2018; 47(5):333-342. PubMed ID: 29779027
[TBL] [Abstract][Full Text] [Related]
8. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results.
Capelli JP; Kushner H
Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868
[TBL] [Abstract][Full Text] [Related]
9. Association between Severe Anemia and Outcomes of Hemodialysis Vascular Access.
Locham S; Mathlouthi A; Dakour-Aridi H; Nejim B; Malas MB
Ann Vasc Surg; 2020 Jan; 62():295-303. PubMed ID: 31449946
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
Foley RN; Curtis BM; Parfrey PS
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.
Streja E; Kovesdy CP; Greenland S; Kopple JD; McAllister CJ; Nissenson AR; Kalantar-Zadeh K
Am J Kidney Dis; 2008 Oct; 52(4):727-36. PubMed ID: 18760517
[TBL] [Abstract][Full Text] [Related]
12. It's time to compare anemia management strategies in hemodialysis.
Coyne DW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
[TBL] [Abstract][Full Text] [Related]
13. The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial.
Coyne DW
Kidney Int; 2012 Jul; 82(2):235-41. PubMed ID: 22437411
[TBL] [Abstract][Full Text] [Related]
14. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.
Bradbury BD; Do TP; Winkelmayer WC; Critchlow CW; Brookhart MA
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):932-40. PubMed ID: 19572312
[TBL] [Abstract][Full Text] [Related]
15. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
16. Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients.
Sturm G; Lamina C; Zitt E; Lhotta K; Lins F; Freistätter O; Neyer U; Kronenberg F
Nephrol Dial Transplant; 2010 Aug; 25(8):2715-22. PubMed ID: 20190241
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin variability and mortality: confounding by disease severity.
Weinhandl ED; Peng Y; Gilbertson DT; Bradbury BD; Collins AJ
Am J Kidney Dis; 2011 Feb; 57(2):255-65. PubMed ID: 20801571
[TBL] [Abstract][Full Text] [Related]
18. Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial.
Lau JH; Gangji AS; Rabbat CG; Brimble KS
Nephrol Dial Transplant; 2010 Dec; 25(12):4002-9. PubMed ID: 20530806
[TBL] [Abstract][Full Text] [Related]
19. Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.
Fort J; Cuevas X; García F; Pérez-García R; Lladós F; Lozano J; Martín-Malo A;
Nephrol Dial Transplant; 2010 Aug; 25(8):2702-10. PubMed ID: 20176608
[TBL] [Abstract][Full Text] [Related]
20. Anemia Increases Mortality After Open or Endovascular Treatment in Patients with Critical Limb Ischemia: A Retrospective Analysis.
Velescu A; Clará A; Cladellas M; Peñafiel J; Mateos E; Ibañez S; Mellado M
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):543-9. PubMed ID: 26810343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
